DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Navimed Capital Advisors, LLC
Navimed Capital Advisors, LLC
Private equity with venture activity · probableRosslyn, VAnavimed.comSEC registered investment adviser
registered adviser; venture funds are 0% of 3 private funds
Importance
42
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
15
moderate
Identity and regulatory footprint
- Headquarters
- Rosslyn, VAadviserinfo.sec.gov
- Office address
- 1300 WILSON BOULEVARD, SUITE 910, Rosslyn, VA, 22209-2321sec.gov
- Business phone
- (202) 817-2850adviserinfo.sec.gov
- Website
- HTTP://WWW.NAVIMED.COM
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 28, 2024
- Private funds reported
- 3 (0 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $475Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $475Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 11
- business email
- info@navimed.comnavimed.compublished by the subject
- business phone
- (202) 817-2850adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
26 observed deals
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- not stated or not yet read
- Geography
- minnesota, washington, dc
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 26
Funds and vehicles
4 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Navimed Partners II, L.P. | Fund · ADV: Private Equity Fund | 2020 adv first reported | Mature | $331M Mar 28, 2024 | 54 | unknown | unknown |
| Navimed Capital Advisors, LLC | Fund | 2019 form d first sale | Mature | unknown | unknown | $166M | Oct 23, 2020 |
| Navimed Partners, L.P. | Fund · ADV: Private Equity Fund | 2013 form d first sale | Harvest | $139M Mar 28, 2024 | 25 | $108M of $108M | Jul 13, 2015 |
| Navimed Partners Executive Fund, L.P. | Fund · ADV: Private Equity Fund | 2013 form d first sale | Harvest | $5.5M Mar 28, 2024 | 11 | $4.1M | Feb 18, 2015 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
23 current, 1 departed
Chris Lindland
AssociateAssociate
Justin Divelbiss
AssociateAssociate
Scottie Miller
AssociateAssociate
Robert F. Higgins
Founder or executiveChairman
Bijan Salehizadeh
Managing partnerManaging Member, Managing Director, And Member Of The Investment Committee · since Jun 1, 2011
Brian Todd Canann
Managing partnerManaging Member, Managing Director, And Member Of The Investment Committee · since Jun 1, 2011
Ryan Merle Schwarz
Managing partnerManaging Member, Managing Director, And Member Of The Investment Committee · since Jun 1, 2011
Thomas Strauss
OtherEXECUTIVE PARTNERS
Beth Landry
PartnerRyan Schwarz Managing Director
Brian Canann
PartnerManaging Director
Ryan Ross
PartnerManaging Director
Ryan Schwarz
PartnerManaging Director
Ryan Scott Ross
PartnerManaging Director And Member Of The Investment Committee · since Jan 1, 2024
Anika Dieguez
Platform and operationsDirector of Firm Operations
Holly Atallah
Platform and operationsChief Financial Officer
KUN Seung Lee
Platform and operationsChief Compliance Officer · since Mar 1, 2024
Mariana Musiienko
Platform and operationsAccounting Manager
Savannah Kovac
Platform and operationsExecutive Assistant
Vice Presidentz
Platform and operationsof Portfolio Operations
Bennett Mears
PrincipalPrincipal
Josh Boylan
PrincipalPrincipal
Charlie Mangum
Vice presidentSenior Associate
Joe Stief
Vice presidentSenior Associate
1 departed (kept with end dates)
- Rodd Jeffrey Macklin · Chief Financial Officer And Chief Compliance Officer · Mar 1, 2020 to Mar 31, 2023 Inference
Investments on record
26 edges, 26 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
5 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
26 dated events
- Sep 16, 2026Velocityclinical no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceVelocityclinicalVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Tiltstory no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceTiltstoryVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Primetherapypartners no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferencePrimetherapypartnersVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Opnhc no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceOpnhcVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Neuliferehab no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceNeuliferehabVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Metrixgroup no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceMetrixgroupVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Lucenthealth no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceLucenthealthVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Lighthouselabservices no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceLighthouselabservicesVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Goinfusive no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceGoinfusiveVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Thecmgroup no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceThecmgroupVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Clarimed no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceClarimedVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Citrushealthgroup no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceCitrushealthgroupVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Centerpointehospital no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceCenterpointehospitalVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Brentcarebh no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceBrentcarebhVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Enablecomp no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceEnablecompVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026Advantagewoundcare no longer listed on Navimed Capital Advisors, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceAdvantagewoundcareVenture organization websites (about, team, portfolio, thesis, news pages)
- Jan 1, 2024Ryan Scott Ross joined Schedule A of Navimed Capital Advisors, LLC as Managing Director And Member Of The Investment Committee
- Mar 31, 2023Rodd Jeffrey Macklin (Chief Financial Officer And Chief Compliance Officer) no longer on Schedule A of Navimed Capital Advisors, LLC
- Mar 1, 2023KUN Seung Lee joined Schedule A of Navimed Capital Advisors, LLC as Chief Financial Officer And Vp Of Compliance
- Oct 23, 2020NaviMed Partners II, L.P. filed Form D/A: $165,861,527 sold (indefinite offering), Other Investment Fund
- Mar 30, 2020Navimed Partners II, L.P. first reported on Form ADV by Navimed Capital Advisors, LLC (Private Equity Fund), GAV $128,901,070Fund first reported on Form ADVFundsFactNavimed Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 1, 2020Rodd Jeffrey Macklin joined Schedule A of Navimed Capital Advisors, LLC as Chief Financial Officer And Chief Compliance Officer
- Sep 27, 2019NaviMed Partners II, L.P. filed Form D: no sales yet (indefinite offering), Other Investment Fund
- Oct 30, 2013Navimed Partners Executive Fund, L.P. first reported on Form ADV by Navimed Capital Advisors, LLC (Venture Capital Fund), GAV $4,083,626Fund first reported on Form ADVFundsFactNavimed Partners Executive Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 30, 2013Navimed Partners, L.P. first reported on Form ADV by Navimed Capital Advisors, LLC (Venture Capital Fund), GAV $41,138,181Fund first reported on Form ADVFundsFactNavimed Partners, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 30, 2013Navimed Capital Advisors, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 0% of 3 private funds
Evidence
81 observations from 3 sources